The same research group showed that a combination acetylcholinesterase (AChE) inhibitors and activators of nAChRs can lead to beneficial effects in the symptomatic treatment of Alzheimer's disease (Zoli et al., 2015; Kowal et al., 2019). This evidence concerns the gene ACHE and Alzheimer disease.